HeimCRL • NYSE
add
Charles River Lbrtrs ntrntl Inc
223,15 $
Eftir lokun(0,00%)0,00
223,15 $
Lokað: 17. júl., 16:09:05 GMT-4 · USD · NYSE · Lagalegir fyrirvarar
Við síðustu lokun
227,31 $
Dagbil
223,03 $ - 231,39 $
Árabil
161,65 $ - 275,00 $
Markaðsvirði
11,49 ma. USD
Meðalmagn
476,73 þ.
V/H-hlutf.
26,18
A/V-hlutfall
-
Aðalkauphöll
NYSE
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
(USD) | mar. 2024info | Breyting á/á |
---|---|---|
Tekjur | 1,01 ma. | -1,73% |
Rekstrarkostnaður | 209,59 m. | 0,46% |
Nettótekjur | 72,96 m. | -29,26% |
Hagnaðarhlutfall | 7,21 | -28,04% |
Hagnaður á hvern hlut | 2,27 | -18,35% |
EBITDA | 228,53 m. | -8,31% |
Virkt skatthlutfall | 24,77% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
(USD) | mar. 2024info | Breyting á/á |
---|---|---|
Reiðufé og skammtímafjárfestingar | 327,04 m. | 62,23% |
Heildareignir | 8,15 ma. | 5,89% |
Heildarskuldir | 4,45 ma. | -2,06% |
Eigið fé alls | 3,70 ma. | — |
Útistandandi hlutabréf | 51,51 m. | — |
Eiginfjárgengi | 3,22 | — |
Arðsemi eigna | 4,38% | — |
Ávöxtun eigin fjár | 5,27% | — |
Peningaflæði
Breyting á handbæru fé
(USD) | mar. 2024info | Breyting á/á |
---|---|---|
Nettótekjur | 72,96 m. | -29,26% |
Handbært fé frá rekstri | 129,89 m. | 18,75% |
Reiðufé frá fjárfestingum | -85,79 m. | 49,12% |
Reiðufé frá fjármögnun | 18,35 m. | -27,32% |
Breyting á handbæru fé | 54,06 m. | 267,23% |
Frjálst peningaflæði | 38,88 m. | 200,52% |
Um
Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the pharmaceutical, medical device and biotechnology industries. It also supplies assorted biomedical products, outsourcing services, and animals for research and development in the pharmaceutical industry and offers support in the fields of basic research, drug discovery, safety and efficacy, clinical support, and manufacturing.
According to the company, it supported the development of approximately 85% of novel FDA-approved drugs in 2021.
Its customers include leading pharmaceutical, biotechnology, agrochemical, government, and academic organization around the globe. The company has over 90 facilities, operates in 20 countries, and employs approximately 18,400 people worldwide.
Charles River Laboratories is often criticized by animal rights activists who condemn the company's usage of dogs and non-human primates for pharmaceutical purposes. The company is also a major harvester of horseshoe crab blood. Wikipedia
Framkvæmdastjóri
Stofnsett
1947
Höfuðstöðvar
Vefsvæði
Starfsfólk
21.100